Vertex Pharmaceuticals
VRTX
#175
Rank
C$161.33 B
Marketcap
C$629.25
Share price
-0.41%
Change (1 day)
-2.42%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$10.42 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are C$10.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Vertex Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$8.78 B28.65%
2023-12-31C$6.83 B18.77%
2022-12-31C$5.75 B35.41%
2021-12-31C$4.24 B8.67%
2020-12-31C$3.90 B33.99%
2019-12-31C$2.91 B18.25%
2018-12-31C$2.46 B30.47%
2017-12-31C$1.89 B-9.74%
2016-12-31C$2.09 B7.47%
2015-12-31C$1.94 B35.6%
2014-12-31C$1.43 B40.26%
2013-12-31C$1.02 B-34.09%
2012-12-31C$1.55 B19.8%
2011-12-31C$1.29 B6.29%
2010-12-31C$1.22 B35.07%
2009-12-31C$0.90 B0.25%
2008-12-31C$0.90 B173.75%
2007-12-31C$0.32 B-31.94%
2006-12-31C$0.48 B34.16%
2005-12-31C$0.36 B-41.12%
2004-12-31C$0.61 B-11.16%
2003-12-31C$0.68 B-0.13%
2002-12-31C$0.69 B-3.64%
2001-12-31C$0.71 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
C$51.22 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$188.57 B 1,709.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$107.25 B 929.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.15 B 937.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 1,405.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
C$0.30 B-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA